Amicus Therapeutics Inc (FOLD) stock news · rev $634.2M
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
This FOLD news page leads with what Amicus Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for FOLD yet. We will not pad this page with generic market recap.
Latest reported FOLD revenue for 2025-12-31 was $634.2M. Net income was -$27.1M. Revenue was up 20.0% from 2024-12-31 to 2025-12-31. FOLD currently screens at market cap $1.80B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the FOLD stock page; for the tape open the quote page.
FOLD stock news FAQ
What are FOLD's latest revenue and net income?
Latest cached Amicus Therapeutics Inc (FOLD) revenue for Dec 31, 2025 was $634.2M. Net income was -$27.1M. Statements: https://lician.com/financials/fold
How did FOLD revenue change from the prior cached period?
Cached Amicus Therapeutics Inc (FOLD) revenue was up 20.0% from $528.3M (Dec 31, 2024) to $634.2M (Dec 31, 2025). Statements: https://lician.com/financials/fold
What is FOLD's market cap?
Amicus Therapeutics Inc (FOLD) market cap is $1.80B on the latest cached fundamentals snapshot.
What kind of company is FOLD?
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Where is FOLD stock news listed?
Cached stock news for Amicus Therapeutics Inc (FOLD) is listed at https://lician.com/news/fold. Filings: https://lician.com/sec/fold
Not investment advice.